陈贞豪：各位好，我是云深处科技的融资总监陈贞豪。我们是一家具身智能机器人公司。过去几年我们是一直专注在机器狗以及人形机器人的研发生产制造 以及销售方面。今年因为具身智能的火热，我们也确实受到了一些资本市场以及社会上的关注。今天非常荣幸能够应邀来跟大家一起进行交流，谢谢。 9月10日，由36氪主办的2025年36氪产业未来大会在中国厦门盛大启幕。本次大会重磅携手商务部主办的"中国国际投资贸易洽谈会"，以"精耕时代，潮涌嘉 禾"为核心主题，倾力打造一场兼具国家高度、产业深度与市场热度的高规格、高价值、高影响力产业盛典。 大会紧密锚定国家战略导向与产业发展前沿，聚焦人工智能、低空经济、先进制造、新能源、大消费五大核心赛道，汇聚行业顶尖力量共商发展路径、擘画 产业未来。在为期两天的议程中，大会以"产业协作链条"为逻辑主线，重点聚焦"政、资、产"三方协同机制，深入探讨如何打破壁垒、整合资源，精准破解 产业发展中的痛点堵点与瓶颈制约。 36氪在产业未来大会策划了一场"AI时代，新电力如何催生产业链式反应"的圆桌对话，ELU（及旗下原力无限）联合创始人刘扬、松禾创投合伙人江冬云、 华方资本合伙人方晓东、云深处科技投融资总监 ...

Group 1 - The Chinese government emphasizes the importance of accelerating the development of the biopharmaceutical industry, focusing on high-quality technological supply and policy support to enhance innovation and produce more effective drugs [1][2] - The government aims to strengthen original innovation and tackle key core technologies, leveraging both government and market resources to foster a collaborative innovation environment [2] - There is a significant market potential for the health industry in China, with a strong emphasis on the development of innovative drugs and the need for timely identification of high clinical value projects [1][2] Group 2 - The government encourages the establishment of comprehensive support systems for biopharmaceutical innovation, including one-stop R&D solutions and collaboration between industry, academia, and research [2] - The integration of artificial intelligence in various stages of drug development, clinical trials, and production is highlighted as a means to enhance industry development [2] - The government also aims to promote the modernization and industrialization of traditional Chinese medicine by applying modern scientific theories and technologies [2]